~~<i id='321A362F01'><strike id='321A362F01'><tt id='321A362F01'><pre id='321A362F01'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

knowledge

author：comprehensive 2025-08-26 10:54:12 - browse：7679

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Diverse clinical trials: Why aren’t we there yet?

knowledge

hotspot

leisure time

explore

hotspot

explore

AdobeThelastdecadehasseenbillionsofdollarsflowintodigitalhealthcompaniesthatpromisetoimproveoutcomes

WSS

With Wegovy coverage, Medicare patients may face high costs

What Kate Middleton's cancer revelation might teach the world

IRA could hurt research into orphan drugs for rare diseases

Telehealth for opioid use disorder is lifesaving

FDA proposes changes to key medical devices approval pathway

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

entertainment

knowledge

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Adam's Take: Intra

Cancer drug shortages should be causing more outrage

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

What does generative AI mean for health care? We asked experts

Private equity could exacerbate cardiology's overuse problem, experts fear

The cancer drug shortage isn’t new — and neither are the solutions

White House touts steps to stem shortages of cancer treatments

Medicare details structure of new drug price negotiation program

WATCH: Why do bright lights make us see spots?

hotspot

How to make the FDA’s new prescription one

Chinese researcher claims birth of first gene

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Yancopoulos of Regeneron works to expand Dupixent success

Will the IRA bring competition to the biologics market?

Pregnancy ages women, but effects reverse after delivery

leisure time

explore

hotspot

explore